Prioritize Your Finished Goods Experience To Bring Medicine To Patients Safely

By Lenette Simonsen, Senior Director, DP & FG Manufacturing; Behrouz Seifi, Associate Director, Program Design; and Morten Lahrmann, Associate Director, FG Manufacturing Science & Technology

Amid the race to deliver a best-in-class therapeutic to patients, the impact of working with an end-to-end manufacturer that offers drug substance, drug product, and finished goods manufacturing cannot be overstated. With the increased development of parenteral drugs for treating chronic ailments including cancer, diabetes, cardiovascular disease, and respiratory illnesses, a variety of biologic drug delivery formats are needed to cover hospital and clinical settings and patient-centric administration.

A full-service manufacturer must offer the technology to accommodate a client’s need for a variety of finished good container formats. Once the drug product has been aseptically filled into the delivery system of choice, a program enters the finished goods manufacturing phase, where it will be assembled, labeled, and packaged for patient use. Download the full article to learn how choosing a contract development and manufacturing organization (CDMO) that can prioritize your objectives and offer a variety of manufacturing capabilities and container formats will help your program thrive.